Based on the fact that tumor cells are more thermolabile and less oxygen resistant than normal cells, a novel minimally invasive tumor treatment modality, magnetic hyperthermia (MHT) is proposed. However, magnetic materials, which are necessities in MHT, are toxic to human tissue if they are excessively employed. Thus, magnetic materials with higher specific absorption rate (SAR) and intrinsic loss power (ILP) values becomes imperative to minimize their clinical application while mitigating damage to normal human tissues under identical treatment temperature conditions. In this study, the incorporation of soft magnetic MnFe2O4 into hard magnetic CoFe2O4 was introduced, leveraging the exchange coupling between these materials to enhance the magnetic saturation (Ms). Subsequently, we combined these magnetic nanomaterials with graphene oxide (GO) to establish an efficient heat conduction pathway, further augmenting the specific absorption rate (SAR) value of the resulting magnetic composites. Our findings reveal that the Mn0.5Co0.5Fe2O4-1%GO composite developed in this investigation boasts superior SAR values and intrinsic loss power (ILP) of 49.7 W/g and 5.90 nHm2/kg, respectively, when compared to other magnetic materials. The nanomaterials synthesized in this study have the potential to significantly enhance the effectiveness of tumor magnetothermal therapy.